Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
28.00
-1.35 (-4.60%)
Nov 20, 2026, 1:30 PM CST
Nang Kuang Pharmaceutical Revenue
Nang Kuang Pharmaceutical had revenue of 503.08M TWD in the quarter ending September 30, 2026, a decrease of -3.96%. This brings the company's total for the last twelve months to 2.09B, down -6.10% year-over-year. In the year 2025, Nang Kuang Pharmaceutical had annual revenue of 2.16B, down -1.71%. That makes Nang Kuang Pharmaceutical the 26,234th largest company in the world by revenue and 1,210th in Taiwan.
Revenue (ttm)
2.09B
Revenue Growth
-6.10%
P/S Ratio
1.35
Revenue / Employee
3.78M
Employees
552
Market Cap
2.83B
Revenue by Geography
- Taiwan 1.70B 78.8%
- Mainland China 209.24M 9.7%
- Japan 101.06M 4.7%
- United States 81.45M 3.8%
- Other Countries 67.60M 3.1%
Fiscal year ended Dec 31, 2025 See the full Nang Kuang Pharmaceutical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.16B | -37.64M | -1.71% |
| Dec 31, 2024 | 2.20B | 49.63M | 2.31% |
| Dec 31, 2023 | 2.15B | 209.74M | 10.81% |
| Dec 31, 2022 | 1.94B | 160.39M | 9.01% |
| Dec 31, 2021 | 1.78B | 25.27M | 1.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.40B |
| Formosa Optical Technology | 4.46B |
| St.Shine Optical | 3.63B |
| Pacific Hospital Supply | 2.43B |
| Bionime | 1.73B |
| Chi Sheng Pharma & Biotech | 1.43B |
| ICARES Medicus | 1.31B |
| Crystalvue Medical | 894.60M |